Synopsis:- IPO worth ₹400 crore with price band ₹304–₹320, lot size 46 shares. GMP suggests flat listing. Funds mainly for ₹170 crore debt reduction. Strong R&D base with 524 registrations, presence across 20 states and 37 countries, but faces regulatory and raw material risks.
The upcoming IPO of GSP Crop Science aims to raise Rs 400 crore through a combination of fresh issue and offer for sale. The fresh issue comprises 0.75 crore shares worth Rs 240 crore, while the offer for sale includes 0.50 crore shares aggregating Rs 160 crore, providing investors an opportunity to participate in the company’s public market debut.
Furthermore, the IPO will opened for subscription on March 16, 2026, and close on March 18, 2026, with listing expected on March 24, 2026, on BSE and NSE. The price band is fixed at Rs 304– Rs 320 per share, with a minimum retail investment of Rs 14,720 for 46 shares.
GMP of GSP Crop Science IPO
As of 17 March 2026, GSP Crop Science’s shares are expected to list around Rs 320 according to the grey market, indicating a 0% premium over the issue price. This suggests a flat listing expectation, reflecting balanced investor interest and a neutral sentiment in the unofficial market ahead of the company’s official stock market debut.
Objective of the IPO
GSP Crop Science plans to utilize the proceeds from its IPO primarily to strengthen its financial position. Around Rs 170 crore from the net proceeds will be used for the repayment or prepayment of certain outstanding borrowings. This move is expected to reduce debt levels and improve the company’s balance sheet, while the remaining funds will support general corporate purposes.
Company Business
GSP Crop Science Limited operates in the agrochemical industry, focusing on manufacturing insecticides, herbicides, fungicides, and plant growth regulators. The company provides crop protection solutions designed to help farmers improve productivity. Its offerings include both formulations and technicals, enabling effective pest, weed, and disease management across a wide range of agricultural crops.
Furthermore, the company has built a diversified market presence with customers spread across 20 states in India and an international footprint across 37 countries. These markets include regions such as North America, Latin America, and the Asia Pacific. Such geographic diversification supports the company’s growth by reducing reliance on a single market.
Additionally, the company has made consistent investments in research and development to strengthen its product portfolio. As of September 2025, it held 524 product registrations, including 395 formulations and 129 technicals. Supported by dedicated R&D facilities and a workforce of 1,221 employees, the company continues to focus on innovation and product development.
Promoter Holding
GSP Crop Science Limited shows a notable valuation shift following its IPO. The company’s EPS increases from Rs 20.87 to Rs 21.22, while the P/E ratio declines from 15.34x to 9.18x, indicating a relatively attractive valuation post listing. Promoters hold 98.32% stake, with the company valued at around Rs 1,488.60 crore in market capitalization.
Financial Performance
GSP Crop Science Limited has demonstrated steady financial positioning supported by balanced profitability and capital efficiency. As of September 2025, the company reported a ROE of 15.62% and ROCE of 15.45%, reflecting stable returns. Meanwhile, a debt-to-equity ratio of 0.55 indicates a moderate leverage profile alongside an EBITDA margin of 16.45%.
Furthermore, the company’s financials highlight consistent balance sheet growth. Total assets increased to Rs 1,491.69 crore by September 2025, while net worth rose to Rs 529.85 crore. At the same time, profit after tax stood at Rs 81.07 crore, supported by EBITDA of Rs 138.86 crore, indicating stable operational performance and gradual expansion.
Lead Manager & Registrar
GSP Crop Science Limited has appointed MUFG Intime India Pvt. Ltd. as the registrar for its IPO, responsible for managing application processing and share allotment. Meanwhile, the issue is being led by Equirus Capital Pvt. Ltd. and Motilal Oswal Investment Advisors Ltd., who are acting as the lead managers overseeing the offering process.
Competitive Strengths:
- A diverse agrochemical product portfolio covering insecticides, herbicides, fungicides, and plant growth regulators, enabling the company to provide comprehensive crop protection solutions to customers.
- Serving a broad and varied customer base across both domestic and international markets, supporting business expansion and geographic diversification.
- Strong internal research and development capabilities focused on innovation, formulation improvement, and continuous product development.
- Advanced manufacturing infrastructure capable of producing a wide range of agrochemical products while emphasizing sustainable production practices.
- Led by experienced promoters and supported by a skilled management team, contributing to strategic decision-making and operational efficiency.
Risk Factor
- The company requires regulatory approvals and registrations from authorities like CIBRC. Failure to obtain or renew these may disrupt operations.
- The company must meet strict technical and quality standards for products; non-compliance could damage its reputation and lead to business losses.
- International operations require regulatory approvals and registrations in multiple countries, and changing foreign regulations could negatively impact business performance.
- Raw material costs form a significant portion of expenses; any increase without corresponding price adjustments may reduce profitability.
- Dependence on limited suppliers for key raw materials may disrupt production if supply issues arise or procurement becomes difficult.
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
The post GSP Crop Science IPO: From Issue Details to Financials, Here’s What You Need to Know appeared first on Trade Brains.